# Study With Heparin Sodium in Subcutaneous Administration

> **NCT03113084** · PHASE1 · SUSPENDED · sponsor: **União Química Farmacêutica Nacional S/A** · enrollment: 38 (estimated)

## Conditions studied

- Heparin

## Interventions

- **BIOLOGICAL:** Sodium Heparin UQ subcutaneous drug administration
- **BIOLOGICAL:** Sodium Heparin FK subcutaneous drug administration

## Key facts

- **NCT ID:** NCT03113084
- **Lead sponsor:** União Química Farmacêutica Nacional S/A
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** SUSPENDED
- **Start date:** 2022-08-20
- **Primary completion:** 2023-04-20
- **Final completion:** 2023-10-10
- **Target enrollment:** 38 (ESTIMATED)
- **Why stopped:** Delay in the R\&D stage
- **Last updated:** 2019-10-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03113084

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03113084, "Study With Heparin Sodium in Subcutaneous Administration". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03113084. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*